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Abstract: Two new Amaryllidaceae alkaloids, belonging to the mesembrine- and crinine-types,
named crinsarnine (1) and sarniensinol (2), were isolated from the dried bulbs of Nerine sarniensis
together with bowdensine (3), sarniensine (4), hippadine (5) and 1-O-acetyl-lycorine (6). Crinsarnine
(1) and sarniensinol (2) were characterized using spectroscopic and chiroptical methods as
(1S,2S,4aR,10bS)-2,7-dimethoxy-1,2,3,4,4a,6-hexahydro-5,11b-ethano[1,3]dioxolo-[4,5-j]phenanthridin-
1-yl acetate and (6-(3aR,4Z,6S,7aS)-6-methoxy-1-methyl-2,3,3a,6,7,7a-hexa-hydro-1H-indol-3a-yl)benzo
[d][1,3]dioxol-5-yl)methanol, respectively. Furthermore, the complete spectroscopic characterization
of bowdensine (3) is reported for the first time. Compounds 1–6 were evaluated against the
Orlando reference strain of Aedes aegypti. None of compounds showed mortality against 1st instar
Ae. aegypti larvae at the concentrations tested. In adult topical bioassays, only 1 displayed adulticidal
activity with an LD50 = 2.29 ± 0.049 µg/mosquito. As regards the structure-activity relationship,
the pretazettine and crinine scaffold in 2 and 4 and in 1 and 3 respectively, proved to be important
for their activity, while the pyrrole[de]phenanthridine scaffold present in 5 and 6 was important for
their reactivity. Among the pretazettine group compounds, opening of the B ring or the presence of
a B ring lactone as well as the trans-stereochemistry of the A/B ring junction, appears to be important
for activity, while in crinine-type alkaloids, the substituent at C-2 seems to play a role in their activity.
Keywords: Nerine sarniensis; Amaryllidaceae; mesembrine; crinine; crinsarnine; sarniensinol;
bowdensine; Zika virus; Aedes aegypti
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1. Introduction
Aedes aegypti (L.), the yellow fever mosquito, is the primary vector of dengue and yellow fever
viruses. The current Zika virus outbreak is proving to be most concerning since it could easily become
a potential threat to international public health safety if not addressed very soon. The virus causes
microcephaly and other serious brain anomalies during pregnancy [1]. Mosquito control is one of
the main methods used to reduce the spread of the virus. Personal protection, insecticidal treatment
regimens against larval and adult mosquitoes and reduction or complete destruction of mosquito
habitats are among the main methods to reduce such vector-borne diseases [2]. Biological control
strategies such as use of the maternally inherited bacterium Wolbachia pipientis to reduce transmission
of viruses in Ae. aegypti mosquitoes [3] and larvivorous fish represents an alternative to controlling
the Ae. aegypti larvae and pupae [4]. Moreover, extensive use of chemical insecticides for mosquito
control has resulted in the development of pesticide resistance and unwanted environmental effects [5].
Hence, plant based secondary metabolites have attracted considerable interest in pest management
programs as insecticides and repellents. Among them, the Amaryllidaceae plants have demonstrated
to be a good reservoir of alkaloids with a large spectrum of biological activity [6,7]. In fact, in the last
century, Amaryllidaceae plants have stimulated renewed interest in the scientific community due to
the high number of bioactive metabolites isolated from them. There are over 1000 species of these
plants belonging to 60 genera spread widely around the World. In South Africa, these bulbous plants
are grown for their ornamental value and have been used in the past in folk medicine [8,9].
One of the most remarkable groups of natural products isolated from these plants are alkaloids
which present a wide variety of most interesting biological activities. They have been classified into
twelve groups on the basis of their different carbon skeletons [6,7]. To date, literally hundreds of
new structurally diverse alkaloids [10] have been found and many of these have shown promising
anticancer activities, viz., lycorine, isolated for the first time in 1877 is one of the most widely studied
alkaloids for its biological activity [6]. Numerous other Amaryllidaceae alkaloids from different groups,
which include crinamine and the recently discovered pretazettine-type, jonquailine, exhibit interesting
anticancer activities [11]. Among the general Amaryllidaceae alkaloids, galanthamine has proved most
promising and is currently being used as a drug for the treatment of Alzheimer’s disease [12].
Nerine sarniensis cv. Red is a species restricted to the Western Cape of South Africa [13] and
isolation of its alkaloids has been largely unexplored and thus very little is known about these plant
metabolites. The first study of this plant was reported by Boit [14], and was followed by a second study
by our research group [15], who described the isolation of a new mesembrine-type alkaloid, sarniensine
(4, Figure 1), along with tazettine (8, Figure 1), the main alkaloid, lycorine, and 3-epimacronine
(7, Figure 1) from N. sarniensis bulbs. Sarniensine (4) showed adulticidal activity against Aedes aegypti,
a mosquito which is the major vector for dengue, yellow fever and the presently alarming Zika virus [15].
The current paper reports on the isolation and structural determination of additional alkaloids
isolated from N. sarniensis. Two new alkaloids, named crinsarnine (1) and sarniensinol (2), were
isolated together with bowdensine (3), sarniensine (4), hippadine (5) and 1-O-acetyl-lycorine (6).
The latter isolated compounds are now reported for the first time from N. sarniensis, along with the
insecticidal activity of alkaloids 1–8 against Ae. aegypti mosquitoes. Since rather sparse information
was found about the spectral characterization of 3 [16,17], the complete NMR spectroscopic data for
this alkaloid is also reported here for completeness.
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as deduced from its HR ESIMS spectrum, consistent with nine hydrogen deficiencies. The 1H- and 
13C-NMR spectra (Table 1) showed a signal system typical of crinine-type alkaloids. In fact, the 
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3.77 (d, J = 17.3 Hz)/58.3 (H2C-6). In addition, the same spectrum illustrated complex spin systems due 
to the substituted C ring and an ethane-bridge in the D ring. In fact, suitably 1,2,5-substituted W and 
A2B2 systems [20,21] were observed for the protons of the C ring and the ethane-group respectively, 
in which the latter connected the B/C bridgehead carbon C-10b to the tertiary nitrogen atom of the D 
ring. The doublet (J = 3.7 Hz), observed at δ 5.14, was assigned to the esterified methine (HC-1), and 
was coupled in the COSY spectrum [22] with the proton of the adjacent oxygenated methine (HC-2), 
 
N
O
O
6
OH
O
O
H
N
O
5
O
O
NMe
OMe
O
H
O
H
7
O
O
NMe
OMe
O
H
OH
8
2
10
9
8
7
6a
6
5
44a
12
11
10a
10b
1
2
3
N
O
O
OMe
O
R
H
O
O
1  R = Me
3  R = COMe
O
O
A
B
C
D
O
O
NMe
OMe
OMe2'
4
H
O
O
NMe
OMe
OH
6
7
7a
3a
4
5
5'
4'
6'
3'
1'
2'
3 2
1
H
A
B
Figure 1. Structures of crinsarnine (1), sarniensinol (2), bowdensine (3), sarniensine (4), hippadine (5),
1-O-acetyl-lycorine (6), 3-epimacronine (7) and tazettine (8).
2. Results and Discussion
The known alkaloids bowdensine (3), hippadine (5) and 1-O-acetyl-lycorine (6) were isolated for
the first time from N. sarniensis, and were identified by comparison of their spectroscopic properties
with those previously reported in the literature for 3 [16,17], 5 [18] and 6 [19].
The NMR spectra showed that crinsarnine (1) and sarniensinol (2) belong to two different
subgroups of A aryllidaceae alkaloids (Figure 1). Crinsarnine (1) ha a molecular formula of
C20H25NO6 as deduced from its HR ESIMS spectrum, consistent with nine hydrogen deficiencies.
The 1H- and 13C-NMR sp ctra (Table 1) showed a signal ypical of c inine-type alkaloids.
In fact, the 1H-NMR spectrum show d signals of th methylenedioxy system, the single aromatic
proton of a pentasubstituted A ring, the AB system of the nitrogen methylene linked to ring A at δ 5.84
(d, J = 1.3 Hz) and 5.83 (d, J = 1.3 Hz)/100.5 (O-CH2-O), 6.24 (s)/97.5 (HC-10) and 4.19 (d, J = 17.3 Hz)
and 3.77 (d, J = 17.3 Hz)/58.3 (H2C-6). In addition, the same spectrum illustrated complex spin systems
due to the substituted C ring and an ethane-bridge in the D ring. In fact, suitably 1,2,5-substituted
W and A2B2 systems [20,21] were observed for the protons of the C ring and the ethane-group
respectively, in which the latter connected the B/C bridgehead carbon C-10b to the tertiary nitrogen
atom of the D ring. The doublet (J = 3.7 Hz), observed at δ 5.14, was assigned to the esterified methine
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(HC-1), and was coupled in the COSY spectrum [22] with the proton of the adjacent oxygenated
methine (HC-2), which appeared as a broad single peak at δ 3.96. H-2 was coupled with the broad
doublet (J = 13.6 Hz) and broad triplet (J = 13.6 Hz) at δ 2.09 and 1.33, respectively, which were
assigned to the adjacent H2C-3 methylene group. These latter protons were coupled with those
of the adjacent H2C-4 methylene group, appearing as a triple doublet (J = 13.6 and 4.8 Hz) and
a multiplet at δ 1.66 and 1.57, respectively. These, in turn, were coupled with the double doublet
(J = 13.6 and 4.8 Hz) of H-4a observed at δ 3.00 [21]. Considering that ring C assumes a hemi-chair
like conformation, the coupling constants of these signals allowed the authors to locate the signals
of H-3B and H-4B and H-4a as α-, β- and α-axial, as well as H-2, H-3A and H-4A as α-, β- and
α-equatorial. Both 1H- and 13C-NMR spectra also showed the typical singlets of an acetoxy group,
confirmed by the corresponding C=O bands observed in the IR spectrum [23] appearing at δ 170.9
(COOCH3) and 2.22/21.6 (COOCH3) and those of two methoxy groups at δ 3.96/59.1 (OCH3) and
3.31/57.7 (OCH3) [21,24]. The acetoxy group was located at C-1 while the two methoxy groups were
located at C-2 and C-7 as deduced from the HMBC spectrum [22]. The relative stereochemistry at
C-1 is assigned as β-equatorial and was deduced by the absence of any correlation observed in the
NOESY spectrum [22] between both H-1 and H-2 as well as between the 1-acetoxy and 2-methoxy
groups which thus located these two protons in the 1-α- and 2-β-axial orientations, respectively.
The couplings observed in the HSQC spectrum [22] facilitated the assignments of the chemical shifts to
all protonated carbons. Thus, the signals at δ 76.8, 75.8, 68.2, 52.3, 37.3, 24.4 and 20.4 were assigned to
C-1, C-2, C-4a, C-12, C-11, C-3 and C-4. The other couplings observed in the HMBC spectrum allowed
assignment of the remaining aromatic quaternary carbons. In particular, the coupling between C-6a
and H2-6 and H-10, C-7 and H2-6, H-10 and O-CH2-O, C-8 and H2-6, C-9 and O-CH2-O, H-10 and
OMe (C-7), C-10a and H2-6, H-10 and O-CH2-O, allowed the assignment of the signals at δ 148.1,
141.3, 140.3, 133.4 and 116.7 to C-7, C-8, C-9, C-10a and C-6a. [24]. Thus, chemical shifts were
assigned to all the protons and corresponding carbons as reported in Table 1 and 1 was formulated
as (1S,2S,4aR)-2,7-dimethoxy-1,2,3,4,4a,6-hexahydro-5,11b-ethano[1,3]dioxolo[4,5-j]phenanthridin-1-yl
acetate. The structure assigned to 1 was supported by all the HMBC couplings reported in Table 1
and from the data of its HR ESIMS spectrum, which showed the pseudomolecular ion [M + H]+ at
m/z 376.1766.
The (1S,2S,4aR,10bS) absolute configurations of crinsarnine (1) and bowdensine (3) were assigned
by comparing their ECD spectra with those reported in literature for the closely similar crinine
alkaloids [25]. As expected, the ECD spectra of 1 and 3 recorded under the same conditions (Figure 2)
practically overlapped each other, supporting the assigned absolute configurations assigned to them.
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Table 1. 1H-, 13C-NMR and HMBC spectroscopic data of crinsarnine (1) and bowdensine (3) a,b.
No.
1 3
13C c 1H (J in Hz) HMBC 13C c 1H (J in Hz) HMBC
1 76.8 5.14 (1H) d (3.7) H-11 74.1 5.32 (1H) d (4.4) H-2, H-3A, H-11A, COOCH3
2 75.8 3.96 (1H) br s d OMe (2) 68.3 5.57 (1H) br s H-1, H-3B, COOCH3
3 24.4 2.09 (1H) br d (13.6)1.33 (1H) br t (13.6) H-4B, H-4a 26.4
1.94 (1H) br d (14.4)
1.57 (1H) br dd (14.4, 11.4) H-4B
4 20.4 1.66 (1H) td (13.6, 4.8)1.57 (1H) m H-3B, H-4a 21.2
2.06 (1H) td (11.4, 5.5)
1.72 (1H) m H2-3, H-4a
4a 68.4 3.00 (1H) dd (13.6, 4.8) H-3B, H-4B, H-6B, H-11B, H-12A 68.2 3.03 (1H) dd (5.5, 11.4) H-3B, H2-4, H-6B, H-11B, H-12A
6 58.3 4.19 (1H) d (17.3)3.77 (1H) d (17.3) 4a, H2-12 58.4
4.18 (1H) d (17.5)
3.77 (1H) d (17.5) H-4a, H-10, H-12A, H-12B
6a 116.7 H2-6, H-10 117.0 H-6A, H-6B, H-10
7 148.1 H2-6, H-10, OCH2O 148.1 H-10
8 141.3 H-1, H-4a, H2-6, H2-11 141.0 H2-6
9 140.3 H2-6, H-10, OMe (7) 140.3 H-10, OMe
10 97.5 6.24 (1H) s 97.4 6.18 (1H) s
10a 133.4 H2-6, H-10, OCH2O 133.5 H2-6, H-10, OCH2O
10b 124.5 129.7
11 37.3 2.03 (1H) ddd (16.0, 9.2, 4.3)2.92 (1H) ddd (16.0, 11.6, 6.3) H-1, H-4a,H-6A, H-12 37.3
2.74 (1H) ddd (13.0, 11.0, 5.5)
2.03 (1H) ddd (13.0, 9.0, 6.0) H-1, H-4a, H-6A, H-12A
12 52.3 2.79 (1H) ddd (14.6, 11.6, 4.3)3.39 (1H) ddd (14.6, 9.2, 6.3) H-4a, H2-6, H-11A 52.3
3.42 (1H) ddd (12.4, 9.0, 5.5)
2.82 (1H) ddd (12.4, 11.0, 6.0) H-4a, H2-6, H-11A
OCH2O 100.5
5.83 (1H) d (1.3)
5.84 (1H) d (1.3) 100.5
5.84 (1H) d (1.2)
5.83 (1H) d (1.2)
OMe (7) 59.1 3.96 (3H) s d H2-6 59.1 3.97 (3H) s H2-6
OMe (2) 57.7 3.31 (3H) s
COOCH3 (1) 21.6 2.22 (3H) s 21.3 d 2.10 (3H) s d H-1, H-2
COOCH3 (2) 21.3 d 2.10 (3H) s d H-1, H-2
COOCH3 (1) 170.9 H-1, COOCH3 170.1 H-1, H-2, COOCH3 (1)
COOCH3 (2) 170.4 H-2, COOCH3 (2)
a The chemical shifts are in δ values (ppm) from TMS; b 2D 1H, 1H (COSY) 13C, 1H (HSQC) NMR experiments delineated the correlations of all the protons and the corresponding
carbons; c Multiplicities were assigned by DEPT spectrum; d Overlapped signals.
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In the case of acetate 3, only partial 1H-NMR spectral data was available for a comparison [14] and
thus its 1H- and 13C-NMR spectral data (Table 1), also supported by the respective COSY, HSQC and
HMBC spectra, are now fully reported here for completeness and to confirm the assigned structure.
Sarniensinol (2) is here reported as the second new alkaloid isolated from the crude organic
extract of N. sarniensis. Comparison of its 1H- and 13C-NMR spectra (Table 2) with that of sarniensine
(4, Figure 1, recorded under the same conditions), a pretazettine type alkaloid recently isolated from
the same plant [15], illustrated an overlapping in all the spectral regions. One most obvious difference
was the fact that 2 lacked the signal for the methoxy group of the methoxy side chain at C-2′ in 4.
This difference allowed for assigning the chemical shifts to all the protons and corresponding carbons
of 2 on the basis of the clear couplings observed in the respective COSY, HSQC and HMBC spectra and
are reported in Table 2. Thus, 2 was formulated as (6-(6-methoxy-1-methyl-2,3,3a,6,7,7a-hexahydro-
1H-indol-3a-yl)benzo[d][1,3]dioxol-5-yl)methanol. The structure assigned to 2 was confirmed from the
data of its HR ESIMS spectrum which showed the pseudomolecular ion [M + H]+ at m/z 318.1712.
Table 2. 1H-, 13C-NMR and HMBC spectroscopic data of sarniensinol 2 a,b.
No. 13C c 1H (J in Hz) HMBC
2 55.4 t 3.21 (1H) ddd (9.4, 9.1, 8.5)2.50 (1H) ddd (9.4, 18.5, 5.0) H2-3, N-Me
3 39.7 t 2.35 (1H) ddd (13.5, 8.5, 5.0)2.14 (1H) ddd (13.5, 9.1, 18.5) H2-2, N-Me
3a 50.3 s H2-2, H2-3, H-4, H-5, H-6
4 137.1 d 5.83 (1H) br s d H2-3
5 124.4 d 5.83 (1H) br s d H-6, H2-7
6 72.2 d 3.89 (1H) dd (5.7, 10.3) H-5, H2-7, OMe
7 26.6 t 2.20 (1H) dd (11.3, 5.7)1.56 (1H) dd (10.3, 11.3) H-5, H-6
7a 70.8 d 2.67 (1H) br s H2-2, H2-7, N-Me
1′ 129.7 s H2-3, H-6′, CH2OH
2′ 132.5 s H-3′, CH2OH
3′ 111.1 d 6.93 (1H) s CH2OH
4′ 146.2 s H-3′, H-6′, OCH2O
5′ 147.0 s H-3′, H-6′, OCH2O
6′ 109.1 d 6.95 (1H) s H-3′
OCH2O 101.2 t 5.93 (2H) br s
CH2OH 63.0 q
4.77 (1H) d (12.0)
4.69 (1H) d (12.0) H-3
′
OMe 55.8 q 3.39 (3H) s H-6
N-Me 40.4 q 2.39 (3H) s H2-2
OH 3.65, br s
a The chemical shifts are in δ values (ppm) from TMS; b 2D 1H, 1H (COSY) 13C, 1H (HSQC) NMR experiments
delineated the correlations of all the protons and the corresponding carbons; c Multiplicities were assigned by
DEPT spectrum; d Overlapped signals.
The absolute configuration 3aS,4Z,6S,7aS was assigned to 2 by comparing its ECD spectrum with
that of sarniensine (4) recorded under the same conditions (Figure 3) and previously reported [15]
as well as with spectra reported in the literature for egonine and tazettadiol isolated from
Hippeastrum equestre [26]. A notable discovery was that the alkaloids sarniensinol (2), sarniensine (4),
egonine and tazettadiol all displayed similar profiles in the CD spectra in the region between 225
and 260 nm while sarniensinol (2) displayed an opposite Cotton effect with respect to the other three
alkaloids, vide supra, at about 290 nm. This observation suggests that the A/B ring fusion for 2 is
trans and opposite to that of egonine, tazettadiol and sarniensine (4) which are all cis. This opposite
stereochemistry is probably the main reason for the significant different value for the coupling between
the two olefinic protons H-4 and H-5 in ring A appearing as broad singlets compared to the same
protons observed in sarniensine (4) as two doublets with J = 10.5 Hz [15] and in egonine as a doublets
of double doublets with J = 10.6, 2.1 and 1.8 Hz [26].
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Figure 3. ECD spectra of sarniensinol (2), sarniensine (4) and tazettine recorded in MeOH.
In the current study, the isolated compounds crinsarnine (1), sarniensinol (2), bowdensine (3),
hippadine (5) and 1-O-acetyl-lycorine (6) were evaluated for their mosquitocidal activity against
Ae. aegypti and their activities were compared to those of sarniensine (4), 3-epimacronine (7) and
tazettine (8), as previously reported [15]. Initial larval activity testing indicated that none of these
compounds 1–3, 5 and 6 showed enough mortality to be further studied for their dose response
bioassays at the prescreened dosages of 1.00, 0.50, 0.25 and 0.10 µg·µL−1 (Table 3).
Table 3. The initial 24-h mortality testing of compounds 1–8 against 1st instar Ae. aegypti larvae (n = 3).
Compounds
Percent Mortality
1 µg/µL 0.5 µg/µL 0.25 µg/µL 0.1 µg/µL
Crinsarnine (1) 0 0 0 0
Sarniensinol (2) 7 ± 11 0 0 0
Bowdensine (3) 13 ± 11 0 0 0
Hippadine (5) 7 ± 11 0 0 0
1-O-Acetyl-lycorine (6) 0 0 0 0
Sarniensine (4) A 100 ± 0 80 ± 0 60 ± 0 20 ± 0
3-Epimacronine (7) A 60 ± 0 40 ± 0 20 ± 0 0 ± 0
Tazettine (8) A 20 ± 0 0 ± 0 0 ± 0 0 ± 0
Pos tive control per rin at 6.3 pg/µL resulted in 53% ± 11% mortality and at 47.4 pg/µL resulted in
100% ± 0% mortality; negative control solvent control (DMSO) had 0 mortality. A Compounds 4, 7 and 8 were
previously reported [15].
In adult topical bioassays on Ae. aegypti, compound 1 proved to be the most active, with 97% ± 6%
mortality at the test dose of 5 µg·mosquito−1 in three replicated experiments, while the remaining
compounds produced 23% (6) and 33% (2, 3, 5) mortality. Compound 1 was further evaluated and had
an LD50 value of 2.3 µg/mosquito against adult female Ae. aegypti (Table 4).
The results (Table 4), also showed that the pretazettine and crinine carbon skeleton present
in 2, 4 and 7, and in 1 and 3 respectively, are very important for the activity with respect to
pyrrole[de]phenanthridine ring present in 5 and 6. Among the pretazettine group, compound 4
was more active than either 7 or 2, which suggests that opening of the B ring or the presence of
a lactone B ring supports our previous findings [15] where we suggested that these same structural
features played a major role in the biological activity of the isolates of N. sarniensis. Furthermore, in the
same group of alkaloids, the stereochemistry of the A/B ring junction, being trans in 2 and cis in 4
and 7, also appear to play a role. Among the crinine type alkaloids, compound 1 was the most active
metabolite and more so than 3, which suggests that the substituent at C-2 certainly plays a significant
role in the activity profile of the molecule.
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Table 4. Initial 24-h mortality testing of compounds 1–8 against adult female Ae. aegypti (n = 3).
Compound Mortality (%) 5 µg/mosquito LD50 ** ± SE (µg/mosquito) 95% CI R2
Crinsarnine (1) 97 ± 6 2.29 ± 0.049 (2.41–2.17) 0.9735
Sarniensinol (2) 33 ± 6
Bowdensine (3) 33 ± 6
Hippadine (5) 33 ± 6
1-O-Acetyl-lycorine (6) 23 ± 6
Sarniensine (4) A 93 ± 6
3-Epimacronine (7) A 67 ± 6
Tazettine (8) A 23 ± 6
Untreated 0
Solvent Control
(acetone) 0
0.15 ng Permethrin 37 ± 6
0.23 ng Permethrin 63 ± 5
2.37 ng Permethrin 100 ± 0
A Compounds 4, 7 and 8 were previously reported [15]; ** After the primary screening of the compounds,
compounds showing mortality >80% were further subjected to LD50 dose-response bioassays.
3. Materials and Methods
3.1. General Information
ECD and absorption spectra were measured in MeOH at room temperature on a J-815
spectropolarimeter (JASCO, Tokyo, Japan), using 1 cm cells. Optical rotations were measured
in CHCl3 on a JASCO P-1010 polarimeter; IR spectra were recorded as deposit glass film on
a Thermo Electron Corporation Nicolet 5700 FT-IR (Thermo, Waltham, MA, USA) spectrometer
and UV spectra were measured in MeOH on a JASCO V-530 spectrophotometer. 1H- and 13C-NMR
spectra were recorded at 400/100 MHz in CDCl3 on Bruker (Karlsruhe, Germany) spectrometers.
The residual peak of the solvent was used as internal standard in each case. Carbon multiplicities were
determined by DEPT spectra [22]. DEPT, COSY-45, HSQC, HMBC, and NOESY experiments were
performed using the Bruker software programs. HRESIMS and ESI spectra were recorded on Shimadzu
(Kyoto, Japan) LCMS-IT-TOF Mass Spectrometer and Agilent (Milan, Italy) 6230 Accurate-Mass TOF
LC/MS instruments. Analytical and preparative TLC were performed on silica gel (Merck, Darmstadt,
Germany, Kieselgel 60, F254, 0.25 and 0.5 mm respectively) plates. The spots were visualized by
exposure to UV radiation (253), or iodine vapour. Colum chromatography (CC) was performed using
silica gel (Merck, Kieselgel 60, 0.063–0.200 mm).
3.2. Plant Material
Bulbs of Nerine sarniensis were purchased from the South African Bulb Company and three
live specimens are growing in the Botanical Garden at the University of Stellenbosch, Stellenbosch,
South Africa.
3.3. Extraction and Purification of N. sarniensis Bulbs Extract
The organic extract of N. sarniensis dried bulbs was obtained following the procedure previously
described [15]. Briefly, dried and minced bulbs (158.7 g) were macerated with 1% H2SO4, (2 × 850 mL)
overnight at 2 ◦C, filtered through cloth and basified to pH 8 with 12 N NaOH. The aqueous solution
was extracted with EtOAc (6 × 600 mL), the organic extracts were combined, dried (anhydrous
Na2SO4) and evaporated under vacuum to provide a brown oil (1.6 g). The extract was fractionated
via a bioguided process by column chromatography using CHCl3–EtOAc–MeOH (2:2:1) as eluent,
followed by CHCl3–EtOAc–MeOH (85:10:5), MeOH and finally with MeOH–H2O (95:5) affording
twelve groups of homogeneous fractions (AF1-AF12). As reported previously, purification of the AF2
residue (195 mg) yielded sarniensine (4). The residue of fraction AF1 (113 mg) was refractionated
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by column chromatography and eluted with CHCl3–i-PrOH (95:5) and finally with MeOH to give
nine fractions (BF1-BF9). The residue of BF2 (16.6 mg) was further purified by analytical TLC using
n-hexane–EtOAc (7:3) as eluent to afford hippadine (5, 2.1 mg, Rf = 0.57) as an amorphous solid.
The residue of BF5 (11.3 mg) was purified by analytical TLC using CHCl3–i-PrOH (95:5) as eluent,
to yield 3-epimacronine (7, 2.6 mg, Rf = 0.58) as an amorphous solid. Fraction AF3 residue (164 mg)
was purified by column chromatography, using CHCl3–MeOH (9:1) as eluent yielding seven fractions
viz., (CF1-CF7). Fractions CF5 and CF6 contained mainly lycorine. The residue of CF2 (1.5 mg) was
identified as sarniensine (4, Rf = 0.88, column eluent). The residue of CF3 (79 mg) was further purified
by preparative TLC and eluted with EtOAc–MeOH–H2O (90:7:3) as eluent, followed by a second
purification with CHCl3–i-PrOH (9:1) as eluent to afford 1-O-acetyl-lycorine (6, 4 mg), as white
crystals, bowdensine (3, 12 mg) and crinsarnine (1, 4.9 mg) as amorphous solids (Rf = 0.41, 0.32 and
0.27 respectfully). The residue of CF4 (17.1 mg) was further purified by TLC with EtOAc–MeOH–H2O
(85:10:5) as eluent, to afford tazettine (8, 1.2 mg) and sarniensinol (2, 2.2 mg) as amorphous solids.
3.4. Characterization of Compounds
Crinsarnine (1): UV (log ε) λmax 285 (2.4), 235 (3.5), 210 (4.3); CD ([θ]λ): see Figure 2; [α]
25
D : +1.8
◦
(c = 0.49); IR νmax 2926.1, 2853.0, 1734.7, 1616.1, 1477.2, 1234.1, 1091.5, 1044.5 cm−1; 1H- and 13C-NMR
data; see Table 1; HRESIMS m/z: 376.1766 [M + H]+ (calcd. for C20H26NO6, 376.1760).
Sarniensinol (2): UV (log ε) λmax 289 (3.0), 242 (3.3), 207 (4.2); CD ([θ]λ): see Figure 3; [α]
25
D : +50.0
◦
(c = 0.22); IR νmax 3660.8, 2922.9, 1655.5, 1512.5, 1252.5, 1097.2 cm−1; 1H- and 13C-NMR data; see Table 2;
HRESIMS m/z: 318.1712 [M + H]+ (calcd. for C18H24NO4, 318.1705).
Bowdensine (3): CD ([θ]λ): see Figure 2; [α]
25
D : +5.3
◦ (c = 0.46); 1H- and 13C-NMR data; see Table 2;
HRESIMS m/z: 404.1713 [M + H]+ (calcd for C21H26NO7, 404.1709).
3.5. Mosquitoes and Bioassay
Aedes aegypti larvae and adults (Orlando, FL, USA, 1952) used in this study were sourced from
laboratory colonies maintained at the USDA-ARS (CMAVE, Gainesville, FL, USA). Rearing larvae
from eggs has been described previously [15,27,28]. Larvicidal activity was performed as described
previously [15,27]. Embryonated eggs were hatched overnight from oviposition papers in deionized
water with a larval diet. Test compounds were initially diluted in DMSO to make 100 µg/µL. Mortality
was determined in the larval assays at four different concentrations (1.0, 0.5, 0.25, and 0.1 µg/µL) in
a final volume of 200 µL of larval rearing media that contained five 1st. For each assay, a positive
control of permethrin stock and a negative control of DMSO was included. Assays were repeated at
least three times on separate days.
To determine the toxicity of each sample against female Ae. aegypti, samples were initially diluted
to a 10% DMSO solution that was subsequently serially diluted 1:10 in acetone. Mosquitoes were
cold anesthetized on ice and groups of 10 females sorted into individual plastic cups. Application of
0.5 µL of the appropriate dilution of the test alkaloid was made by repeater pipettor (PB600, Hamilton,
Reno, NV, USA) with a 25 µL blunt tip glass syringe (Hamilton 7100 series). Mortality was scored
24 h after application. Tests were replicated three times. Compounds showing mortality >80% were
further assessed for LD50 dose-response bioassays, as described previously [15]. Permethrin was used
as positive control and acetone alone as negative control in all bioassays. Mortality data was analyzed
in SigmaPlot.v13 using the best fit sigmoidal plot with the minimum and maximum constrained to 0%
and 100%, respectively.
4. Conclusions
Two new Amaryllidaceae alkaloids, belonging to the mesembrine and crinine type, named
crinsarnine (1) and sarniensinol (2) were isolated from the dried bulbs of N. sarniensis together with
bowdensine (3), sarniensine (4), hippadine (5) and 1-O-acetyl-lycorine (6). Crinsarnine (1) was the only
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one that showed adulticidal activity and appears to possess potential as a natural based insecticide
against Ae. aegypti, the major vector for dengue, yellow fever and the Zika virus. A more integrated
and environmentally friendly insect control system requires models for the development of new
insecticides based on natural strategies. The results described here illustrate that natural products,
and particularly the Amaryllidaceae alkaloids, are valuable resources which need to be investigated
further as natural pesticides against Ae. aegypti, the major vector for dengue, yellow fever and of
course the Zika virus.
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